Deferred Tax Assets, Valuation Allowance of ProPhase Labs, Inc. from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ProPhase Labs, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • ProPhase Labs, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $17,113,000, a 2918% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ProPhase Labs, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $17,113,000 +$16,546,000 +2918% 31 Dec 2024 10-K 01 Apr 2025 2024 FY
Q4 2023 $567,000 -$257,000 -31% 31 Dec 2023 10-K 01 Apr 2025 2024 FY
Q4 2022 $824,000 -$1,354,000 -62% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $2,178,000 -$2,793,000 -56% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q4 2020 $4,971,000 +$261,000 +5.5% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $4,710,000 +$522,000 +12% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $4,188,000 -$106,000 -2.5% 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q4 2017 $4,294,000 -$16,094,000 -79% 31 Dec 2017 10-K 26 Mar 2019 2018 FY
Q4 2016 $20,388,000 +$1,002,000 +5.2% 31 Dec 2016 10-K/A 20 Aug 2018 2017 FY
Q4 2015 $19,386,000 +$1,632,000 +9.2% 31 Dec 2015 10-K/A 20 Aug 2018 2017 FY
Q4 2014 $17,754,000 +$2,698,000 +18% 31 Dec 2014 10-K 24 Feb 2017 2016 FY
Q4 2013 $15,056,000 -$266,000 -1.7% 31 Dec 2013 10-K 29 Mar 2016 2015 FY
Q4 2012 $15,322,000 -$271,000 -1.7% 31 Dec 2012 10-K 27 Mar 2015 2014 FY
Q4 2011 $15,593,000 +$897,000 +6.1% 31 Dec 2011 10-K 27 Mar 2014 2013 FY
Q4 2010 $14,696,000 31 Dec 2010 10-K 28 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.